Ceritinib-d7 is derived from 2-Chloro-4-fluoro-5-nitrotoluene (C366770), which is used as a reagent in the synthesis of potent and selective anaplastic lymphoma kinase (ALK-5) inhibitors, used as an anti-tumor treatment. Also used in the synthesis of herbicides; Deuterium labelled analog of the drug Ceritinib (C367365).
